Vancomycin Study in Multiple Sclerosis (MS)

Abroad (travel likely)RecruitingPHASE1

Conditions

Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, New York, United States
Contact: Study coordinator (Susan E Filomena, BA) · susan.filomena@mssm.edu · 212-241-3841
Contact: Study coordinator (Abigail Hintermeister, MPA) · abigail.hintermeister@mssm.edu · 212-241-3391
Contact: Principal Investigator (Stephanie K Tankou)

Study leads

Stephanie K Tankou, MD
Principal Investigator
Icahn School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis · Primary Progressive Multiple Sclerosis · Secondary Progressive Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE1

London, United Kingdom

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

Multiple Sclerosis · Sleep · Pain

Abroad (travel likely)RecruitingPHASE2

Ann Arbor, United States

The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis (SPMS)

Abroad (travel likely)RecruitingPHASE2

Giza, Egypt

Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis

Stroke · Multiple Sclerosis

Abroad (travel likely)Recruiting

Kaposvár, Hungary